Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions - Test2 - elhamkhani - TriplyDB

Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions

Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions

http://www.wikidata.org/entity/Q26750131

about

The role of active brown adipose tissue (aBAT) in lipid metabolism in healthy Chinese adults.Acute chest pain after bench press exercise in a healthy young adult Clinical Evaluation of a Polyherbal Nutritional Supplement in Dyslipidemic Volunteers.The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study.IndEcho study: cohort study investigating birth size, childhood growth and young adult cardiovascular risk factors as predictors of midlife myocardial structure and function in South Asians.Almonds and Cardiovascular Health: A Review.Statins everyday versus alternate days: Is there a difference in myalgia rates?Serum Lipid Profile and Its Association with Diabetes and Prediabetes in a Rural Bangladeshi Population Differential associations of cardio-metabolic diseases by population group, gender and adiposity in South Africa

P2860

Q37209641-306103AC-2508-4EBA-8E16-C497EF4AA0A2 Q37283943-99E73A36-E54B-4015-B63E-E797A198A34C Q39240307-B44AD6AC-C8EB-4818-8022-3FB67155164F Q47139777-102ED2B2-71BA-4C83-BB76-95475B7502AE Q52593277-AC29EDB7-115D-44F9-9D33-E4709D7B55F8 Q55109092-169D3C27-589D-40B8-896C-E330041B6F14 Q56975988-AC9FAE65-D1B6-4C27-95F4-2E4C836853D0 Q57927450-67698DDF-9EF8-40C2-9970-60A4F9046644 Q58691831-9E8E752E-F9CF-40D4-8F6D-FB97B7447976

P2860

Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions

http://www.wikidata.org/entity/Q26750131

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Lipoprotein abnormalities in S ...... nt state and future directions

@ast

Lipoprotein abnormalities in S ...... nt state and future directions

@en

Lipoprotein abnormalities in S ...... nt state and future directions

@nl

type

label

Lipoprotein abnormalities in S ...... nt state and future directions

@ast

Lipoprotein abnormalities in S ...... nt state and future directions

@en

Lipoprotein abnormalities in S ...... nt state and future directions

@nl

prefLabel

Lipoprotein abnormalities in S ...... nt state and future directions

@ast

Lipoprotein abnormalities in S ...... nt state and future directions

@en

Lipoprotein abnormalities in S ...... nt state and future directions

@nl

P1433

Q26750131-F52E7CC4-37E1-4E78-805E-E5579FA5FD6B

P1476

Q26750131-FE471341-E0FF-4D55-8239-2CB3619C6409

P2093

Q26750131-2DE9DFDE-2D55-4146-B64C-3E6D6CFFC95A

Q26750131-DBDD59D9-CE24-40D1-BFBE-8567883D02A5

P2860

Q26750131-0044A323-6BA2-4AD1-B5C7-E13B656D5A6C

Q26750131-00CEFDF6-3E9F-400D-A1BE-687CE36F2794

Q26750131-01E05E24-C00B-4782-AB95-25002E599978

Q26750131-03E775D5-537B-433F-ACCF-8CC6CE7B9B0B

Q26750131-072FA0F8-17F0-41B8-BA85-873F340FCB85

Q26750131-07A276C9-F277-437F-8BB6-D70E14E9990D

Q26750131-0BA0C00E-8F0D-49BA-9251-6C0C4C3DFC5F

Q26750131-0DCA4CEB-A5C6-4688-A650-8C555ADFD921

Q26750131-111EE722-EA87-4C6D-9EDD-44F2B9A53D88

Q26750131-112EEE1B-905C-43BD-ADE2-F19FA2DFB0A6

P304

Q26750131-9C378FEB-5B8E-482E-AD61-EE543EC1F23B

P31

Q26750131-68CF4DFA-9190-4D4C-964A-FDA82AEF1E63

P3181

Q26750131-EB505CD3-CA8D-4042-94E3-BA5A9EE2FFE5

P356

Q26750131-E80DAD28-C3D3-4FC9-ADE7-9333095A46C8

P407

Q26750131-CD0BF6CE-3C36-4D96-A58C-255ACB6E5B9F

P433

Q26750131-0E3FF734-5730-45DB-B954-890C6F7DA18A

P478

Q26750131-14F80626-6610-4D1F-B980-E8E0FE78CA7A

P50

Q26750131-83D783D2-0856-4EA8-9381-CBD2ADD2A4F8

P577

Q26750131-370CB168-795B-4E98-AF1E-5D709EE45AEC

P698

Q26750131-0A53224C-5FE4-4B45-A1F8-B5979F5E3BAB

P921

Q26750131-61E3CB1D-7070-45C7-ACFE-0407AB7BE83A

Q26750131-BBEAC57B-D5AB-47CC-98A0-2BC4DB6AD1E9

P932

Q26750131-4EA2AB5F-6289-4835-A8FF-6F08EEE5C0CF

P3181

P356

P1433

World journal of cardiology

P1476

Lipoprotein abnormalities in S ...... nt state and future directions

@en

P2093

Ozlem Bilen

http://www.w3.org/2001/XMLSchema#string

Salim S Virani

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative levels and time trends in blood pressure, total cholesterol, body mass index and smoking among Caucasian and South-Asian participants of a UK primary-care based cardiovascular risk factor screening programme.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Serum levels of lipoprotein (a) and other lipids in angiographically defined coronary artery disease patients and healthy blood bank donors.

P304

247-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3383624

http://www.w3.org/2001/XMLSchema#string

P356

10.4330/WJC.V8.I3.247

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ayeesha Kamran Kamal

P577

2016-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27022456

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4807313

http://www.w3.org/2001/XMLSchema#string